Allergic aspergillosis of the respiratory tract

European Respiratory Review

Volumn 23, Issue 131, 2014, Pages 8-29

  Shah, Ashok ^a   Panjabi, Chandramani ^b  

^a UNIVERSITY OF DELHI   (India)

^b Mata Chanan Devi Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FUNGUS ANTIBODY; GLUCOCORTICOID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; ITRACONAZOLE; OMALIZUMAB; PREDNISOLONE; PREDNISONE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLOMA; ASTHMA; CHEMOSENSITIZATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; EOSINOPHIL COUNT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; LUNG FUNCTION TEST; NONHUMAN; PLEURA EFFUSION; RESPIRATORY TRACT DISEASE; SKIN TEST; SPUTUM EXAMINATION; THORAX RADIOGRAPHY;

ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS; ASTHMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; PREDICTIVE VALUE OF TESTS; PULMONARY ASPERGILLOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84895471576     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/09059180.00007413     Document Type: Article

References (215)

1. Shah A. Allergic bronchopulmonary aspergillosis. Indian J Chest Dis Allied Sci 1998; 40: 41-54.
2. de Shazo RD, Chapin K, Swain RE. Fungal sinusitis. N Engl J Med 1997; 337: 254-259.
3. Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis: a review and a report of eight new cases. Thorax 1952; 7: 317-333.
4. Shah A, Panjabi C. Allergic bronchopulmonary aspergillosis: a review of a disease with a worldwide distribution. J Asthma 2002; 39: 273-289.
5. Longbottom JL, Pepys J. Pulmonary aspergillosis, diagnostic and immunological significance of antigens and Creactive substance in Aspergillus fumigatus. J Pathol Bacteriol 1964; 88: 141-151.
6. Hendrick DJ, Davies RJ, D'Souza MF, et al. An analysis of skin prick test reactions in 656 asthmatic patients. Thorax 1975; 30: 2-8.
7. Schwartz HJ, Citron KM, Chester EH, et al. A comparison of the prevalence of sensitization to Aspergillus antigens among asthmatics in Cleveland and London. J Allergy Clin Immunol 1978; 62: 9-14.
8. Maurya V, Gugnani SC, Sarma PU, et al. Sensitization to Aspergillus antigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma. Chest 2005; 127: 1252-1259.
9. Fairs A, Agbetile J, Hargadon B, et al. IgE sensitisation to Aspergillus fumigatus is sssociated with reduced lung function in asthma. Am J Respir Crit Care Med 2010; 182: 1362-1368.
10. Menzies D, Holmes L, McCumesky G, et al. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy 2011; 66: 679-685.
11. Agarwal R, Noel V, Aggarwal AN, et al. Clinical significance of Aspergillus sensitisation in bronchial asthma. Mycoses 2011; 54: e531-e538.
12. Agbetile J, Fairs A, Desai D, et al. Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy 2012; 42: 782-791.
13. Zureik M, Neukirch C, Leynaert B, et al. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. Br Med J 2002; 325: 411-414.
14. Kauffman HF, van der Heide S. Exposure, sensitization, and mechanisms of fungus-induced asthma. Curr Allergy Asthma Rep 2003; 3: 430-437.
15. Denning DW, O'Driscoll BR, Hogaboam CM, et al. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27: 615-626.
16. Denning DW, O'Driscoll BR, Powell G, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med 2009; 179: 11-18.
17. Pasqualotto AC, Powell G, Niven R, et al. The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis. Respirology 2009; 14: 1121-1127.
18. Greenberger PA. When to suspect and work up allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 2013; 111: 1-4.
19. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110: 685-692.
20. Patterson R. Allergic bronchopulmonary aspergillosis and hypersensitivity reactions to fungi. In: Fishman AP, Elias JA, Fishman JA, et al., eds. Fishman's Pulmonary Diseases and Disorders. 3rd Edn. Vol. 1. New York, McGraw-Hill & Co., 1998; pp. 777-782.
21. Kramer MN, Kurup VP, Fink JN. Allergic bronchopulmonaty aspergillosis from a contaminated dump site. Am Rev Respir Dis 1989; 140: 1086-1088.
22. Allmers H, Huber H, Baur X. Two year follow-up of a garbage collector with allergic bronchopulmonary aspergillosis (ABPA). Am J Ind Med 2000; 37: 438-442.
23. Graves TS, Fink JN, Patterson R, et al. A familial occurrence of allergic bronchopulmonary aspergillosis. Ann Intern Med 1979; 91: 378-382.
24. Shah A, Khan ZU, Chaturvedi S, et al. Concurrent allergic Aspergillus sinusitis and allergic bronchopulmonary aspergillosis associated with familial occurrence of allergic bronchopulmonary aspergillosis. Ann Allergy 1990; 64: 507-512.
25. Shah A, Kala J, Sahay S, et al. Frequency of familial occurrence in 164 patients with allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 2008; 101: 363-369.
26. Wark P. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment. Respir Med 2004; 98: 915-923.
27. Bhatnagar PK, Banerjee B, Shah A, et al. Probable role of IgG subclasses in patients with allergic bronchopulmonary aspergillosis. Serodiagn Immunother Infect Dis 1993; 5: 123-124.
28. Kurup VP. Immunology of allergic bronchopulmonary aspergillosis. Indian J Chest Dis Allied Sci 2000; 42: 225-237.
29. Kauffman HF, Tomee JFC, Vander Werf TS, et al. Review of fungus induced asthmatic reactions. Am J Respir Crit Care Med 1995; 151: 2109-2116.
30. Wark PAB, Gibson PG. Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment. Respirology 2001; 6: 1-7.
31. Madan T, Banerjee B, Bhatnagar PK, et al. Identification of 45 kD antigen in immune complexes of patients of allergic bronchopulmonary aspergillosis. Mol Cell Biochem 1997; 166: 111-116.
32. Purkayastha S, Madan T, Shah A, et al. Multifunctional antigens of Aspergillus fumigatus and specific antibodies. Appl Biochem Biotech 2000; 83: 271-286.
33. Chauhan B, Knutsen A, Hutcheson PS, et al. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 1996; 97: 2324-2331.
34. Chauhan B, Santiago L, Kirschmann DA, et al. The association of HLADR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 1997; 159: 4072-4076.
35. Chauhan B, Santiago L, Hutcheson PS, et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000; 106: 723-729.
36. Miller PW, Hamosh A, Macek M Jr, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996; 59: 45-51.
37. Marchand E, Verellen-Dumoulin C, Mairesse M, et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001; 119: 762-767.
38. Eaton TE, Weiner Miller P, Garrett JE, et al. Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the aetiology of allergic bronchopulmonary aspergillosis? Clin Exp Allergy 2002; 32: 756-761.
39. Lebecque P, Pepermans X, Marchand E, et al. ABPA in adulthood: a CFTR-related disorder. Thorax 2011; 66: 540-541.
40. de Almeida MB, Bussamra MH, Rodrigues JC. Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients. Paediatr Respir Rev 2006; 7: 67-72.
41. Madan T, Kishore U, Shah A, et al. Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin Exp Immunol 1997; 110: 241-249.
42. Madan T. Potential of lung surfactant proteins, SP-A and SP-D, and mannan binding lectin for therapy and genetic predisposition to allergic and invasive aspergillosis. Recent Pat Inflamm Allergy Drug Discov 2007; 1: 183-187.
43. Saxena S, Madan T, Shah A, et al. Association of polymorphisms in the collagen region of SPA2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2003; 111: 1001-1007.
44. Vaid M, Kaur S, Sambatakou H, et al. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med 2007; 45: 183-186.
45. Knutsen AP, Kariuki B, Consolino JD, et al. IL-4 alpha chain receptor (IL-4Ralpha) polymorphisms in allergic bronchopulmonary aspergillosis. Clin Mol Allergy 2006; 4: 3.
46. Brouard J, Knauer N, Boelle PY, et al. Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis. J Infect Dis 2005; 191: 1988-1991.
47. Sambatakou H, Pravica V, Hutchinson IV, et al. Cytokine profiling of pulmonary aspergillosis. Int J Immunogenet 2006; 33: 297-302.
48. Kaur S, Gupta VK, Shah A, et al. Plasma mannan-binding lectin levels and activity are increased in allergic patients. J Allergy Clin Immunol 2005; 116: 1381-1383.
49. Kaur S, Gupta VK, Shah A, et al. Elevated levels of mannan-binding leptin (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol 2006; 143: 414-419.
50. Carvalho A, Pasqualotto AC, Pitzurra L, et al. Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 2008; 197: 618-621.
51. Madan T, Priyadarsiny P, Vaid M, et al. Use of a synthetic peptide epitope of Asp f 1, a major allergen or antigen of Aspergillus fumigatus, for improved immunodiagnosis of allergic bronchopulmonary aspergillosis. Clin Diagn Lab Immunol 2004; 11: 552-558.
52. Gautam P, Sundaram CS, Madan T, et al. Identification of novel allergens of Aspergillus fumigatus using immunoproteomics approach. Clin Exp Allergy 2007; 37: 1239-1249.
53. Shah A. Allergic bronchopulmonary aspergillosis: a view from India. Saudi Med J 2002; 23: 1559-1561.
54. Novey HS. Epidemiology of allergic bronchopulmonary aspergillosis. Immunol Allergy Clin North Am 1998; 18: 641-653.
55. Henderson AH, English MP, Vecht RJ. Pulmonary aspergillosis: a survey of its occurrence in patients with chronic lung disease and a discussion of the significance of diagnostic tests. Thorax 1968; 23: 513-518.
56. Adiseshan N, Simpson J, Gandevia B. The association of asthma with Aspergillus and other fungi. Aust N Z J Med 1971; 4: 385-391.
57. Patterson R, Golbert TM. Hypersensitivity disease of the lung. Univ Mich Med Cent J 1968; 34: 8-11.
58. Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 1988; 81: 646-650.
59. Schwartz HJ, Greenberger PA. The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med 1991; 117: 138-142.
60. Eaton T, Garrett J, Milne D, et al. Allergic bronchopulmonary aspergillosis in the asthma clinic: a prospective evaluation of CT in the diagnostic algorithm. Chest 2000; 118: 66-72.
61. Greenberger PA. Allergic bronchopulmonary aspergillosis. In: Middleton E Jr, Reed CE, Ellis EF, et al., eds. Allergy: Principles and Practice. 5th Edn. St. Louis, CV Mosby Co, 1998; pp. 981-993.
62. Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37: Suppl. 3, S225-S264.
63. Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 2013; 51: 361-370.
64. Benatar SR, Keen GA, Du Toit Naude W. Aspergillus hypersensitivity in asthmatics in Cape Town. Clin Allergy 1980; 10: 285-291.
65. Donnelly SC, McLaughlin H, Bredin CP. Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985-88. Ir J Med Sci 1991; 160: 288-290.
66. Al-Mobeireek AF, El-Rab Mogad, Al-Hedaithy SS, et al. Allergic bronchopulmonary mycosis in patients with asthma: period prevalence at a university hospital in Saudi Arabia. Respir Med 2001; 95: 341-347.
67. Ma YL, Zhang WB, Yu B, et al. Prevalence of allergic bronchopulmonary aspergillosis in Chinese patients with bronchial asthma. Zhonghua Jie He He Hu Xi Za Zhi 2011; 34: 909-913.
68. Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy 2013; 43: 850-873.
69. Agarwal R, Gupta D, Aggarwal AN, et al. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest 2007; 132: 1183-1190.
70. Prasad R, Garg R, Sanjay, et al. A study on prevalence of allergic bronchopulmonary aspergillosis in patients of bronchial asthma. Internet J Pulm Med 2008; 9: DOI: 10.5580/1418.
71. Sarkar A, Mukherjee A, Ghoshal AG, et al. Occurrence of allergic bronchopulmonary mycosis in patients with asthma: an Eastern India experience. Lung India 2010; 27: 212-216.
72. Ghosh T, Dey A, Biswas D, et al. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis among asthma patients in eastern India. J Indian Med Assoc 2010; 108: 863-865.
73. Rosenberg M, Patterson R, Mintzer R, et al. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977; 86: 405-414.
74. Wang JLF, Patterson R, Rosenberg M, et al. Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1978; 117: 917-927.
75. Shah A. Allergic bronchopulmonary aspergillosis: an emerging disease in India. Indian J Chest Dis Allied Sci 1994; 36: 169-172.
76. Scadding JG. The bronchi in allergic aspergillosis. Scand J Respir Dis 1967; 48: 372-377.
77. Patterson R, Greenberger PA, Halwig JM, et al. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986; 146: 916-918.
78. Glancy JJ, Elder JL, McAleer R. Allergic bronchopulmonary fungal disease without clinical asthma. Thorax 1981; 36: 345-349.
79. Berkin KE, Vernon DRH, Kerr JW. Lung collapse caused by allergic bronchopulmonary aspergillosis in nonasthmatic patients. Br Med J 1982; 285: 552-553.
80. Hoshino H, Tagaki S, Kon H, et al. Allergic bronchopulmonary aspergillosis due to Aspergillus niger without bronchial asthma. Respiration 1999; 66: 369-372.
81. Sanchez-Alarcos JMF, Martinez-Cruz R, Ortega L, et al. ABPA mimicking bronchogenic cancer. Allergy 2001; 56: 80-81.
82. Shah A, Maurya V, Panjabi C, et al. Allergic bronchopulmonary aspergillosis without clinical asthma caused by Aspergillus niger. Allergy 2004; 59: 236-237.
83. Koh WJ, Han J, Kim TS, et al. Allergic bronchopulmonary aspergillosis coupled with broncholithiasis in a nonasthmatic patient. J Korean Med Sci 2007; 22: 365-368.
84. Ricketti AJ, Greenberger PA, Patterson R. Immediate-type reactions in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1983; 71: 541-545.
85. Shah A, Bhagat R, Panchal N. Allergic bronchopulmonary aspergillosis with clubbing and cavitation. Indian Pediatr 1993; 30: 248-251.
86. Shah A, Kala J, Sahay S. Allergic bronchopulmonary aspergillosis with hilar adenopathy in a 42-month-old boy. Pediatr Pulmonol 2007; 42: 747-748.
87. Imbeau SA, Cohen M, Reed CE. Allergic bronchopulmonary aspergillosis in infants. Am J Dis Child 1977; 131: 1127-1130.
88. Shah A. Allergic bronchopulmonary aspergillosis: an Indian perspective. Curr Opin Pulm Med 2007; 13: 72-80.
89. McCarthy DS, Pepys J. Allergic bronchopulmonary aspergillosis. Clinical immunology: 1. Clinical features. Clin Allergy 1971; 1: 261-286.
90. Safirstein BH, D'Souza MF, Simon G, et al. Five year follow up of bronchopulmonary aspergillosis. Am Rev Respir Dis 1973; 108: 450-459.
91. Shah A, Panchal N, Panjabi C. Allergic bronchopulmonary aspergillosis: a review from India. Allergy Clin Immunol Int J World Allergy Org 2003: Suppl. 1, 104.
92. Shah A. Allergic bronchopulmonary aspergillosis. Allergy Clin Immunol Int J World Allergy Org 2005; 17: 172-180.
93. Panchal N, Bhagat R, Pant C, et al. Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances. Respir Med 1997; 91: 213-219.
94. Shah A, Panchal N, Agarwal AK. Allergic bronchopulmonary aspergillosis: the spectrum of roentgenologic appearances. Indian J Radiol Imag 1999; 9: 107-112.
95. McCarthy DS, Simon G, Hargeave FE. The radiological appearances in allergic bronchopulmonary aspergillosis. Clin Radiol 1970; 21: 366-375.
96. Mintzer RA, Roger LF, Kruglik GD. The spectrum of radiologic findings in allergic bronchopulmonary aspergillosis. Radiology 1978; 127: 301-307.
97. Phelan MS, Kerr IH. Allergic bronchopulmonary aspergillosis: the radiological appearances during long-term follow up. Clin Radiol 1984; 35: 385-392.
98. Shah A. Allergic bronchopulmonary and sinus aspergillosis: the roentgenologic spectrum. Front Biosci 2003; 8: e138-e146.
99. Hantsch CE, Tanus T. Allergic bronchopulmonary aspergillosis with adenopathy. Ann Intern Med 1991; 115: 546-547.
100. Shah A, Aggarwal AK, Chugh IM. Hilar adenopathy in allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 1999; 82: 504-506.
101. Shah A, Bhagat R, Panchal N, et al. Allergic bronchopulmonary aspergillosis with middle lobe syndrome and allergic Aspergillus sinusitis. Eur Respir J 1993; 6: 917-918.
102. Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis. Model of bronchopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease. Chest 1987; 91: Suppl. 6, 165S-171S.
103. Panchal N, Pant CS, Bhagat R, et al. Central bronchiectasis in allergic bronchopulmonary aspergillosis: comparative evaluation of computed tomography of the thorax with bronchography. Eur Respir J 1994; 7: 1290-1293.
104. Fisher MR, Mendelson EB, Mintzer RA, et al. Use of linear tomography to confirm the diagnosis of allergic bronchopulmonary aspergillosis. Chest 1985; 87: 499-502.
105. Shah A, Pant CS, Bhagat R, et al. Computed tomography in childhood allergic bronchopulomonary aspergillosis. Pediatr Radiol 1992; 22: 227-228.
106. Webb WR, Muller NL, Naidich DP, eds. High-resolution CT of the Lung. 2nd Edn. New York, Lippincott Williams and Wilkins, 1996; pp. 257-258.
107. Mitchell TAM, Hamilos DL, Lynch DA, et al. Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis (ABPA). J Asthma 2000; 37: 65-72.
108. Hansell DM, Strickland B. High-resolution computed tomography in pulmonary cystic fibrosis. Br J Radiol 1989; 62: 1-5.
109. Shah A, Khan ZU, Chaturvedi S, et al. Allergic bronchopulmonary aspergillosis with co-existent aspergilloma: a long term follow up. J Asthma 1989; 26: 109-115.
110. Agarwal AK, Bhagat R, Panchal N, et al. Allergic bronchopulmonary aspergillosis with aspergilloma mimicking fibrocavitory pulmonary tuberculosis. Asian Pac J Allergy Immunol 1996; 14: 5-8.
111. Goyal R, White CS, Templeton PA, et al. High attenuation mucous plugs in allergic bronchopulmonary aspergillosis: CT appearance. J Comput Assist Tomogr 1992; 16: 649-650.
112. Murphy D, Lane DJ. Pleural effusion in allergic bronchopulmonary aspergillosis: two case reports. Br J Dis Chest 1981; 75: 91-95.
113. Bhagat R, Shah A, Jaggi OP, et al. Concomitant allergic bronchopulmonary aspergillosis and allergic Aspergillus sinusitis with an operated aspergilloma. J Allergy Clin Immunol 1993; 91: 1094-1096.
114. O'Connor TM, O'Donnell A, Hurley M, et al. Allergic bronchopulmonary aspergillosis: a rare cause of pleural effusion. Respirology 2001; 6: 361-363.
115. Ricketti AJ, Greenberger PA, Glassroth J. Spontaneous pneumothorax in allergic bronchopulmonary aspergillosis. Arch Intern Med 1984; 144: 151-152.
116. Judson MA, Marshall C, Beale G, et al. Pneumothorax and bronchopleural fistula during treatment of allergic bronchopulmonary aspergillosis. South Med J 1993; 86: 1061-1063.
117. Lynch DA. Imaging of asthma and allergic bronchopulmonary mycosis. Radiol Clin North Am 1998; 36: 129-142.
118. Angus RM, Davies ML, Cowan MD, et al. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax 1994; 49: 586-589.
119. Knutsen AP, Bush RK, Demain JG, et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 2012; 129: 280-291.
120. Agarwal R, Aggarwal AN, Gupta D, et al. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis 2009; 13: 936-944.
121. Hutcheson PS, Knutsen AP, Regent AJ, et al. A twelve year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis. Chest 1996; 110: 363-366.
122. Nikolaizik WH, Crameri R, Blaser K, et al. Skin test reactivity to recombinant Aspergillus fumigatus allergen I/a in patients with cystic fibrosis. Int Arch Allergy Immunol 1996; 111: 403-408.
123. Nikolaizik WH, Weichel M, Blaser K, et al. Intracutaneous tests with recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy. Am J Respir Crit Care Med 2002; 165: 916-921.
124. Patterson R, Roberts M. IgE and IgG antibodies against Aspergillus fumigatus in sera of patients with bronchopulmonary allergic aspergillosis. Int Arch Allergy 1974; 46: 150-160.
125. Brummund W, Resnick A, Fink JM, et al. Aspergillus fumigatus-specific antibodies in allergic bronchopulmonary aspergillosis and aspergilloma: evidence for a polyclonal antibody response. J Clin Microbiol 1987; 25: 5-9.
126. Crameri R, Hemmann S, Ismail C, et al. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol 1998; 10: 1211-1216.
127. Kurup VP, Banerjee B, Hemmann S, et al. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 2000; 30: 988-993.
128. Hemmann S, Nikolaizik WH, Schoni MH, et al. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur J Biochem 1998; 28: 1155-1160.
129. Knutsen AP, Hutcheson PS, Slavin RG, et al. IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 2004; 59: 198-203.
130. Greenberger PA, Miller TP, Roberts M, et al. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy 1993; 70: 333-338.
131. Wark PA, Saltos N, Simpson J, et al. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J 2000; 16: 1095-1101.
132. Ouchterlony Ö. Diffusion-in-gel methods for immunological analysis. Prog Allergy 1958; 5: 1-78.
133. Denning DW. Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect 2001; 7: Suppl. 2, 25-31.
134. Denning DW, Riniotis K, Dobrashian R, et al. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37: Suppl. 3, S265-S280.
135. Denning DW, Park S, Lass-Florl C, et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011; 52: 1123-1129.
136. Nichols D, Dopico GA, Braun S, et al. Acute and chronic pulmonary function changes in allergic bronchopulmonary aspergillosis. Am J Med 1979; 67: 631-637.
137. Panjabi C, Shah A. Lung functions in allergic bronchopulmonary aspergillosis. Respirology 2006; 11: A38.
138. Patterson R, Greenberger PA, Radin RC, et al. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med 1982; 96: 286-291.
139. Greenberger PA, Patterson R. Diagnosis and management of allergic bronchopulmonary aspergillosis. Ann Allergy 1986; 56: 444-448.
140. Shah A, Bhagat R, Pant K, et al. Allergic bronchopulmonary aspergillosis with aspergilloma: exacerbation after prolonged remission. Indian J Tuberc 1993; 40: 39-41.
141. Ramachandran S, Shah A, Pant K, et al. Allergic bronchopulmonary aspergillosis and Candida albicans colonization of the respiratory tract in corticosteroid dependent asthma. Asian Pac J Allergy Immunol 1990; 8: 123-126.
142. Agarwal R, Khan A, Gupta D, et al. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS One 2010; 5: e15346.
143. Fink JN. Therapy of allergic bronchopulmonary aspergillosis. Indian J Chest Dis Allied Sci 2000; 42: 221-224.
144. Rosenberg M, Patterson R, Roberts M, et al. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med 1978; 64: 599-606.
145. Wang JLF, Patterson R, Roberts M, et al. The management of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1979; 120: 87-92.
146. Vlahakis NE, Aksamit TR. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 2001; 76: 930-938.
147. Agarwal R, Gupta D, Aggarwal AN, et al. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 2006; 130: 442-448.
148. Patterson K, Strek ME. Allergic bronchopulmonary aspergillosis. Proc Am Thorac Soc 2010; 7: 237-244.
149. Shah A, Panjabi C. Biweekly therapy with prednisolone is effective in the management of allergic bronchopulmonary aspergillosis. Allergy Clin Immunol Int-J World Allergy Org, 2005: Suppl. 1, 113.
150. Skowronski E, Fitzgerald DA. Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis. Med J Aust 2005; 182: 482-483.
151. Thomson JM, Wesley A, Byrnes CA, et al. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis. Pediatr Pulmonol 2006; 41: 164-170.
152. Cohen-Cymberknoh M, Blau H, Shoseyov D, et al. Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis. J Cyst Fibros 2009; 8: 253-257.
153. Malo JL. Antifungal therapy for allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2003; 111: 934-935.
154. Leon EE, Craig TJ. Antifungals in the treatment of allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 1999; 82: 511-517.
155. Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342: 756-762.
156. Wark PA, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111: 952-957.
157. Pasqualotto AC, Denning DW. Generic substitution of itraconazole resulting in sub-therapeutic levels and resistance. Int J Antimicrob Agents 2007; 30: 93-94.
158. Howard SJ, Cerar D, Anderson MJ, et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009; 15: 1068-1076.
159. Howard SJ, Pasqualotto AC, Denning DW. Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis. Clin Microbiol Infect 2010; 16: 683-688.
160. Hilliard T, Edwards S, Buchdahl R, et al. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros 2005; 4: 215-220.
161. Mulliez P, Croxo C, Roy-Saint Georges F, et al. Aspergillose broncho-pulmonaire allergique traitée par voriconazole [Allergic broncho-pulmonary aspergillosis treated with voriconazole]. Rev Mal Respir 2006; 23: 93-94.
162. Bandres Gimeno R, Munoz Martinez MJ. Respuesta terapéutica prolongada a voriconazol en un caso de broncoaspergilosis alérgica [Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis]. Arch Bronconeumol 2007; 43: 49-51.
163. Erwin GE, Fitzgerald JE. Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole. J Asthma 2007; 44: 891-895.
164. Chishimba L, Niven RM, Cooley J, et al. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma 2012; 49: 423-433.
165. Clancy CJ, Nguyen MH. Long-term voriconazole and skin cancer: is there cause for concern? Curr Infect Dis Rep 2011; 13: 536-543.
166. van der Ent CK, Hoekstra H, Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 2007; 62: 276-277.
167. Zirbes JM, Milla CE. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol 2008; 43: 607-610.
168. Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol 2008; 43: 1249-1251.
169. Perez-de-Llano LA, Vennera MC, Parra A, et al. Effects of omalizumab in Aspergillus-associated airway disease. Thorax 2011; 66: 539-540.
170. Tillie-Leblond I, Germaud P, Leroyer C, et al. Allergic bronchopulmonary aspergillosis and omalizumab. Allergy 2011; 66: 1254-1256.
171. Collins J, Devos G, Hudes G, et al. Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab. J Asthma Allergy 2012; 5: 65-70.
172. Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 1999; 115: 364-370.
173. Mastella G, Rainisio M, Harms HK, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Eur Respir J 2000; 16: 464-471.
174. Geller DE, Kaplowitz H, Light MJ, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Reported prevalence, regional distribution, and patient characteristics. Chest 1999; 116: 639-646.
175. Agarwal R, Hazarika B, Gupta D, et al. Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA? Med Mycol 2010; 48: 988-994.
176. Mir E, Shah A. Allergic bronchopulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. Prim Care Respir J 2012; 21: 111-114.
177. Eppinger TM, Greenberger PA, White DA, et al. Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J Allergy Clin Immunol 1999; 104: 1265-1272.
178. Sharma B, Sharma M, Bondi E, et al. Kartagener's syndrome associated with allergic bronchopulmonary aspergillosis. Med Gen Med 2005; 7: 25.
179. Taylor RG, Joyce H, Gross E, et al. Bronchial reactivity to inhaled histamine and annual rate of decline in FEV1 in male smokers and ex-smokers. Thorax 1985; 40: 9-16.
180. Burrows B, Halonen M, Barbee RA, et al. The relationship of serum immunoglobulin E to cigarette smoking. Am Rev Respir Dis 1981; 124: 523-525.
181. Taylor RG, Gross E, Joyce H, et al. Smoking, allergy and the differential white blood cell count. Thorax 1985; 40: 17-22.
182. Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2000; 356: 1480-1485.
183. Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax 1994; 49: 825-834.
184. Patterson R. Allergic bronchopulmonary aspergillosis: a historical perspective. Immunol Allergy Clin North Am 1998; 18: 471-478.
185. Chowdhary A, Agarwal K, Kathuria S, et al. Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview. Crit Rev Microbiol 2013 [In press DOI: 10.3109/1040841X.2012.754401].
186. Shah A, Panchal N, Agarwal AK. Concomitant allergic bronchopulmonary aspergillosis and allergic Aspergillus sinusitis: a review of an uncommon association. Clin Exp Allergy 2001; 31: 1896-1905.
187. Sharma P, Agarwal AK, Shah A. Formation of an aspergilloma in a patient with allergic bronchopulmonary aspergillosis on corticosteroid therapy. Indian J Chest Dis Allied Sci 1998; 40: 269-273.
188. Shah A, Panjabi C. Contemporaneous occurrence of allergic bronchopulmonary aspergillosis, allergic Aspergillus sinusitis, and aspergilloma. Ann Allergy Asthma Immunol 2006; 96: 874-878.
189. Katzenstein AL, Sale SR, Greenberger PA. Allergic Aspergillus sinusitis: a newly recognised form of sinusitis. J Allergy Clin Immunol 1983; 72: 89-93.
190. Shah A, Khan ZU, Sircar M, et al. Allergic Aspergillus sinusitis: an Indian report. Respir Med 1990; 84: 249-251.
191. Millar JW, Johnston A, Lamb D. Allergic aspergillosis of the maxillary sinuses. Thorax 1981; 36: 710.
192. Shah A, Sircar M. Sensitization to Aspergillus antigens in perennial rhinitis. Asian Pac J Allergy Immunol 1991; 9: 137-139.
193. Sahay S, Shah A. Allergic rhinitis: Aspergillus sensitisation increases the severity of sinusitis in "blockers" as compared to "sneezers and runners". Allergy 2008; 63: 73.
194. Bartynski JM, McCaffrey TV, Frigas E. Allergic fungal sinusitis secondary to dematiaceous fungi: Curvularia lunata and Alternaria. Otolaryngol Head Neck Surg 1990; 103: 32-39.
195. Manning SC, Schaefer SD, Close LG, et al. Culture-positive allergic fungal sinusitis. Arch Otolaryngol Head Neck Surg 1991; 117: 174-178.
196. Corey JP, Delsupehe KG, Ferguson BJ. Allergic fungal sinusitis: allergic, infectious, or both? Otolaryngol Head Neck Surg 1995; 113: 110-119.
197. Schubert MS, Goetz DW. Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis. J Allergy Clin Immunol 1998; 102: 387-394.
198. Mukherji SK, Figueroa RE, Ginsberg LE, et al. Allergic fungal sinusitis: CT findings. Radiology 1998; 207: 417-422.
199. Schubert MS. Allergic fungal sinusitis: pathogenesis and management strategies. Drugs 2004; 64: 363-374.
200. Sher TH, Schwartz HJ. Allergic Aspergillus sinusitis with concurrent allergic bronchopulmonary Aspergillus: report of a case. J Allergy Clin Immunol 1988; 81: 844-846.
201. Schwartz HJ, Witt WJ, Sher TH. Allergic bronchopulmonary aspergillosis and allergic aspergillus sinusitis: case report. Ann Allergy 1992; 69: 447-448.
202. Venarske DL, deShazo RD. Sinobronchial allergic mycosis: the SAM syndrome. Chest 2002; 121: 1670-1676.
203. Braun JJ, Pauli G, Schultz P, et al. Allergic fungal sinusitis associated with allergic bronchopulmonary aspergillosis: an uncommon sinobronchial allergic mycosis. Am J Rhinol 2007; 21: 412-416.
204. Prasad R, Garg R, Sanjay. Concomitant allergic bronchopulmonary aspergillosis and allergic fungal sinusitis. Indian J Med Sci 2007; 61: 532-534.
205. Diwakar A, Panjabi C, Shah A. Allergic bronchopulmonary aspergillosis, allergic Aspergillus sinusitis and their cooccurrence. Open Allergy J 2008; 1: 52-61.
206. Cody DT 2nd, Neel HB 3rd, Ferreiro JA, et al. Allergic fungal sinusitis: the Mayo clinic experience. Laryngoscope 1994; 104: 1074-1079.
207. Campbell JM, Graham M, Gray HC, et al. Allergic fungal sinusitis in children. Ann Allergy Asthma Immunol 2006; 96: 286-290.
208. Kurashima A. Analysis of the course of non-invasive pulmonary aspergillosis. Jpn J Med Mycol 1997; 38: 167-174.
209. McCarthy DS, Pepys J. Pulmonary aspergilloma: clinical immunology. Clin Allergy 1973; 3: 57-70.
210. Ein ME, Wallace RJ Jr, Williams TW. Allergic bronchopulmonary aspergillosis-like syndrome consequent to aspergilloma. Am Rev Respir Dis 1979; 119: 811-820.
211. Pendleton M, Denning DW. Multifocal pulmonary aspergillomas: case series and review. Ann NY Acad Sci 2012; 1272: 58-67.
212. Shah A. Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Eur Respir Rev 2010; 19: 261-263.
213. Agarwal R, Aggarwal AN, Garg M, et al. Allergic bronchopulmonary aspergillosis with aspergilloma: an immunologically severe disease with poor outcome. Mycopathologia 2012; 174: 193-201.
214. Shah A. Asthma and Aspergillus. Indian J Chest Dis Allied Sci 2004; 46: 167-170.
215. Panjabi C, Shah A. Allergic Aspergillus sinusitis and its association with allergic bronchopulmonary aspergillosis. Asia Pac Allergy 2011; 1: 130-137.